Buy-signal for the Moderna share: Although the biotech stock recorded a NASDAQ closing price of 78.29 dollars yesterday, well below the daily high of 81.37 dollars, the previous breakout above the technical chart resistance at 75.39 / 76.25 dollars remains intact. The positive trend in today’s US pre-exchange also confirms the buy signal for the company’s share, which is developing a vaccine against the pathogen of the corona pandemic, among other things.
For the Moderna share, the technical picture improves significantly. The stock had previously fallen from its all-time high of $ 95.21 to $ 54.21, but was able to build support at this level and then move into a continued unbroken upward movement. In the meantime, this has produced various technical buy signals for the Moderna share, most recently at 70.90 / 72.20 dollars.
The two chart marks that have been overcome now become technical chart support for Moderna’s share price in the event of a setback. Further resistance levels above yesterday’s highs are on the biotech stock chart at $ 82.43 / $ 82.82 and $ 83.85 / 84.29.